NASDAQ
Jounce Therapeutics, Inc. (JNCE) has a free cash flow growth of 285.69% as of Friday, May 29, 2026. This represents a 209.67% increase compared to its 12-month average of -260.51%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.